Clinical Trial Update: Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics

View source ↗

Summary

This clinical trial investigates methotrexate for Juvenile Idiopathic Arthritis guided by pharmacogenomics and pharmacometrics. The trial status is not disclose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Juvenile Idiopathic Arthritis | Status: UNKNOWN